Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07567495 · ClinicalTrials.gov registry record · Phase 4
Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery
A Phase 4 study, sponsored by Columbia University.
- Not yet
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT07567495 is a Phase 4 study that has not yet begun recruiting, run by Columbia University. The registered enrollment target is 150 participants.
The verdict
NCT07567495, a Phase 4 study, has not yet begun recruiting, sponsored by Columbia University.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study will examine whether addition of dexmedetomidine or clonidine (two alpha-2 adrenergic agonists) will improve the comfort of patients during spinal anesthesia for cesarean delivery. When added to standard spinal anesthesia consisting of bupivacaine (a local anesthetic) and fentanyl and morphine (two opioids), these medications may decrease some of the pulling/tugging/pressure sensations that patients sometimes feel during cesarean delivery, may prolong the anesthetic time, and may decrease postoperative pain.
Interventions
- DRUG Dexmedetomidine
- DRUG Clonidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07567495
The ClinicalTrials.gov registry entry for NCT07567495 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT07567495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07567495 about?
NCT07567495 is a clinical study titled "Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery". This study will examine whether addition of dexmedetomidine or clonidine (two alpha-2 adrenergic agonists) will improve the comfort of patients during spinal anesthesia for cesarean delivery. When added to standard spinal anesthesia consisting of bupivacaine (a local anesthetic) and fentanyl and mor...
What is the current status of trial NCT07567495?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2026-06. Estimated completion is 2028-05.
What interventions are being tested in trial NCT07567495?
The interventions under investigation include: Dexmedetomidine (DRUG), Clonidine (DRUG).
Who is sponsoring clinical trial NCT07567495?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.